Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?

DIMITRIOS KOUTROTSIOS

2 hours ago

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ramp up production enough.

Source link

About the Author

DIMITRIOS KOUTROTSIOS

This author has not added a biography. Meanwhile DIMITRIOS KOUTROTSIOS has contributed 3277 posts. Click here to view them.